Malignant melanoma is one of the most common malignant tumors, especially in adolescent age groups. However, given the state of knowledge on the proliferation and antigenicity pattern of tumor cells, an ideal use of modern immunotherapeutic and targeted approaches is offered. Meanwhile, expansion of treatment options to early stages and in the neoadjuvant setting has improved recurrence- and progression-free survival.
This content is machine-translated. Please contact us if you need professional translation services.
Autoren
- Leoni Burggraf
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
You May Also Like
- Cardiovascular risk in IBD
Cause for concern?
- Microplastics in kidneys and urine
Life in plastic … is not fantastic
- Asthma and psyche
When fear makes you lose your breath
- COPD: Update for the primary care physician
Counteract exacerbations and improve quality of life
- Stroke
Not on the brain – the latest findings on strokes
- Atopic dermatitis: choice of systemic therapy option
“It’s always an individual weighing”.
- Do low carb diets harm the heart?
Keto diet associated with hypercholesterolemia and increased risk of ASCVD
- Cardiovascular events in CKD